Published Date: 26 Apr 2023
By using interpretation and translation to present information to communities in their native language, public health outreach initiatives frequently aim to break down communication barriers. However, bilingual people from various cultural backgrounds.
Read Full Newsargenx's efgartigimod-alfa therapy was approved for seropositive generalized myasthenia gravis in 2021.
Early initiation of opicapone significantly reduces OFF time and enhances ON time in patients with recently diagnosed Parkinson's disease, improving overall treatment outcomes.
The FDA requested the full data from the phase 3 HOPE-3 study as part of its review of the biologics license application for deramiocel, which Capricor plans to submit in February 2026.
A five-year analysis from the National RLS Opioid Registry found that most patients with dopamine agonist augmented restless legs syndrome maintained stable, low-dose opioid therapy with sustained symptom control.
Personalized Care Improvements Identified for Older Patients with Skin Cancer
New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc
What to Expect at the 2026 Maui Derm Conference
1.
If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version
2.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
3.
Early-life exposure to air and light pollution linked to increased risk of pediatric thyroid cancer
4.
Survival is extended by a new treatment option for metastatic colorectal cancer.
5.
Immunotherapy Is As Safe As Other Cancer Treatments During Pregnancy.
1.
Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies
2.
Advancements in Cancer Treatment Strategies for Non-Hodgkin Lymphoma
3.
Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control
4.
The Unfolding Revolution of Precision Medicine, Immunotherapy, and Digital Transformation in Medical Oncology 2025
5.
KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
2.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
4.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation